Cargando…
Glycosylation of Immune Receptors in Cancer
Evading host immune surveillance is one of the hallmarks of cancer. Immune checkpoint therapy, which aims to eliminate cancer progression by reprogramming the antitumor immune response, currently occupies a solid position in the rapidly expanding arsenal of cancer therapy. As most immune checkpoints...
Autores principales: | Sun, Ruoxuan, Kim, Alyssa Min Jung, Lim, Seung-Oe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147841/ https://www.ncbi.nlm.nih.gov/pubmed/34064396 http://dx.doi.org/10.3390/cells10051100 |
Ejemplares similares
-
N-Glycosylation Facilitates 4-1BB Membrane Localization by Avoiding Its Multimerization
por: Sun, Ruoxuan, et al.
Publicado: (2022) -
4-1BB: A promising target for cancer immunotherapy
por: Kim, Alyssa Min Jung, et al.
Publicado: (2022) -
The Glycosylation of Immune Checkpoints and Their Applications in Oncology
por: Zheng, Linlin, et al.
Publicado: (2022) -
Human T cell glycosylation and implications on immune therapy for cancer
por: De Bousser, Elien, et al.
Publicado: (2020) -
Protein cages as building blocks for superstructures
por: Sun, Ruoxuan, et al.
Publicado: (2021)